Literature DB >> 7808306

Assay of ubiquinones and ubiquinols as antioxidants.

V E Kagan1, E A Serbinova, D A Stoyanovsky, S Khwaja, L Packer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7808306     DOI： 10.1016/0076-6879(94)34104-4

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  10 in total

Review 1.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

Review 2.  Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway.

Authors:  Annalisa Marcuzzi; Elisa Piscianz; Claudia Loganes; Liza Vecchi Brumatti; Alessandra Knowles; Sabrine Bilel; Alberto Tommasini; Roberta Bortul; Marina Zweyer
Journal:  Int J Mol Sci       Date:  2015-12-30       Impact factor: 5.923

3.  Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium.

Authors:  Shasi V Kalivendi; Eugene A Konorev; Sonya Cunningham; Sravan K Vanamala; Eugene H Kaji; Joy Joseph; B Kalyanaraman
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

4.  Redox Pioneer: Professor Valerian Kagan.

Authors:  Hülya Bayır; John J Maguire; Enrique Cadenas
Journal:  Antioxid Redox Signal       Date:  2022-04-21       Impact factor: 7.468

Review 5.  Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope.

Authors:  Showkat Ul Nabi; Andleeb Khan; Ehraz Mehmood Siddiqui; Muneeb U Rehman; Saeed Alshahrani; Azher Arafah; Sidharth Mehan; Rana M Alsaffar; Athanasios Alexiou; Bairong Shen
Journal:  Oxid Med Cell Longev       Date:  2022-05-14       Impact factor: 7.310

Review 6.  The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis.

Authors:  Paolo Puddu; Giovanni M Puddu; Eleonora Cravero; Susanna De Pascalis; Antonio Muscari
Journal:  J Biomed Sci       Date:  2009-12-09       Impact factor: 8.410

Review 7.  Placental mitochondrial dysfunction with metabolic diseases: Therapeutic approaches.

Authors:  Jessica F Hebert; Leslie Myatt
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-10       Impact factor: 5.187

8.  Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics.

Authors:  P Hemachandra Reddy
Journal:  J Biomed Biotechnol       Date:  2006

9.  NLRP3 inflammasome activation by mitochondrial ROS in bronchial epithelial cells is required for allergic inflammation.

Authors:  S R Kim; D I Kim; S H Kim; H Lee; K S Lee; S H Cho; Y C Lee
Journal:  Cell Death Dis       Date:  2014-10-30       Impact factor: 8.469

10.  Solid phase synthesis of mitochondrial triphenylphosphonium-vitamin E metabolite using a lysine linker for reversal of oxidative stress.

Authors:  Mohanad Mossalam; Jamie Soto; Carol S Lim; E Dale Abel
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.